Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin
Be׳eri Niego(Diabetes Australia), Robert L. Medcalf(Monash Medical Centre)
Cited by 48
Related Papers
An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice
|Advanced Materials|2023|33